Form 10-K CBL & ASSOCIATES PROPERT For: Dec 31
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260303/AK2ZS22CZZ2RT2ZZ27Z822YNQTH9ZZ22ZS8G
Filed on: March 3, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CBL & Associates (CBL) PT Raised to $55 at Ladenburg Thalmann
- DC Plan Sponsors to Modernize Investment Menus, According to PIMCO Consulting Study
- Wayrilz (rilzabrutinib, Sanofi) Positioned to Define Third-Line Treatment in Warm Autoimmune Hemolytic Anemia (w-AIHA) as IMAAVY (niopcalimab, Jonhson & Johnson) Follows Closely with Positive Data Ann
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
